Overview
- 4 FDA inspections are on record.
- 2 inspections produced a Form 483.
- The most recent recorded inspection date is 2022-02-18.
At a glance
Inspections
4
Form 483s
2
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 14 Feb 2022 – 18 Feb 2022 | Human Drugs | 483 | View 483 → |
| 6 Mar 2017 – 10 Mar 2017 | Human Drugs | 483 | View 483 → |
| 11 Aug 2011 | Not recorded | Clean | |
| 20 Aug 2009 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
18 Feb 2022
21 CFR 211.110(a)
Control procedures to monitor and validate performance
Cited by Kemejumaka N Opara
Investigators
FDA investigators tied to this site in the record.
Kemejumaka N Opara1 insp.
Daveta L Bailey1 insp.
Kara D Dobbin1 insp.
Randy L Clarida1 insp.
Tracy R Ball1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.110(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(a)(8) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.67(b) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind The Procter & Gamble Manufacturing Company's 2 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat